Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med. 2020 Oct 29;383(18):1757-
1766. doi: 10.1056/NEJMcp2009249.
Karimi M, Haghpanah S, Zarei T, et al. Prevalence and severity of Coronavirus disease 2019 (COVID-19)
in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of
associated comorbidities: an Iranian nationwide study. Acta Biomed. 2020 Sep 7;91(3):e2020007. doi:
10.23750/abm.v91i3.10155.
Karimi M, Haghpanah S, Azarkeivan A, et al. Coronavirus Disease 2019 (COVID-19) Severity in Patients
with Thalassemias: A Nationwide Iranian Experience. Mediterr J Hematol Infect Dis. 2021 Jan
1;13(1):e2021008. doi: 10.4084/MJHID.2021.008.
McCloskey KA, Meenan J, Hall R, Tsitsikas DA. COVID-19 infection and sickle cell disease: a UK centre
experience. Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779.
Motta I, Migone De Amicis M, Pinto VM, et al. SARS-CoV-2 infection in beta thalassemia: Preliminary
data from the Italian experience. Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840.
Nur E, Gaartman AE, van Tuijn CFJ, et al. Vaso-occlusive crisis and acute chest syndrome in sickle cell
disease due to 2019 novel coronavirus disease (COVID-19). Am J Hematol. 2020 Jun;95(6):725-726. doi:
10.1002/ajh.25821.
Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus Disease among Persons with Sickle Cell Disease,
United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct;26(10):2473-2476. doi:
10.3201/eid2610.202792.
Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool
our collective experience. Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880.